Uses of Becovita

Becovita is a drug belonging to the group of mineral and vitamin drugs, used in the prevention and treatment of people with vitamin C deficiency, in combination with other drugs in the treatment of other diseases. Follow the article below to better understand the drug Becovita, as well as how to use this drug.

Becovita is a drug belonging to the group of mineral and vitamin drugs, used in the prevention and treatment of people with vitamin C deficiency, in combination with other drugs in the treatment of other diseases. Follow the article below to better understand the drug Becovita, as well as how to use this drug.

What is Becovita? Becovita is a drug belonging to the group of mineral and vitamin drugs, produced by Meyer-BPC - VIETNAM Joint Venture Company, prepared in the form of film-coated tablets, packaged in blisters: 1 box of 10 blisters, each blister of 10 tablets and Box of 50 or 100 pills.
Becovita drug ingredients include:
Ascorbic acid 50 mg Thiamine mononitrate 2 mg Pyridoxine HCl 1 mg Riboflavin 2 mg Nicotinamide 20 mg Calcium pantothenate 2 mg

Thanks to the ingredients and excipients in the drug, Becovita is indicated in the following cases:
Prevention and treatment of diseases caused by vitamin C deficiency. Prevention and treatment of vitamin B deficiency in cases of deficiency caused by an unbalanced diet, adolescents in the growth period, the elderly, the convalescence period, pregnancy and lactation. In combination with desferrioxamine to increase iron excretion in the treatment of thalassemia. Idiopathic methemoglobinemia when methylene blue is not available. Other indications such as flu prevention, wound healing, cancer prevention have not been proven.

Becovita is contraindicated in the following cases:
Becovita is contraindicated in people with glucose - 6 - phosphate dehydrogenase (G6PD) deficiency (risk of hemolytic anemia). People with a history of kidney stones, increased oxaluria and oxalate metabolism disorders (increased risk of kidney stones). People with thalassemia (increased risk of iron absorption).

4.1.Usage Use Becovita orally. In cases where oral administration is not possible or when malabsorption is suspected, and only in very special cases, should the drug be administered parenterally. When administered parenterally, it is best to inject intramuscularly, even though the drug may cause pain at the injection site.
4.2. Dosage Depending on the medical condition for the doctor to decide the dose of the drug. Becovita has a recommended adult dose of 1 tablet, 2 times a day.
Vitamin C deficiency (scurvy)
Prophylaxis: 25 - 75mg/day (adults and children).
Treatment:
Adults: Dose 250 - 500mg/day divided into several small doses, taken for at least 2 weeks. Children: 100-300mg/day in divided doses, taken for at least 2 weeks. In combination with desferrioxamine to increase iron excretion (due to the increased chelating effect of desferrioxamine): 100-200mg/day.
Methemoglobin - blood when methylene blue is not available: 300 - 600mg/day in divided doses.

Long-term use of high doses of Becovita can lead to drug resistance, so reducing the dose will lead to vitamin C deficiency. Taking large doses of Becovita during pregnancy has led to scurvy in the newborn. Hyperoxaluria can occur after taking high doses of vitamin C. Vitamin C can cause acidification of the urine, sometimes leading to precipitation of urate or cystin, oxalate stones, drugs in the urinary tract. Rapid intravenous injection of vitamin C (inappropriate and unsafe use) may lead to transient fainting or dizziness, and possibly cardiac arrest. Patients with glucose - 6 - phosphate dehydrogenase deficiency taking high doses of vitamin C intravenously or orally may develop hemolysis. Deep vein thrombosis has also occurred after taking high doses of vitamin C.

During the use of Becovita medicine may cause some of the following symptoms:
Diarrhea, stomach pain. Increased oxalate - urine, nausea, hemolytic anemia may occur when taking Becovita drug. Vomiting, abdominal cramps, fatigue, insomnia or drowsiness. In the composition of the drug, riboflavin dyes urine yellow. It is necessary to inform the doctor and stop taking the drug when any allergic reaction occurs.

Missed dose: If you forget to take a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and take your next dose at the scheduled time. Never take double the prescribed dose.
Overdose: If there are unusual symptoms when overdose, the patient should immediately notify the doctor or the person in charge of medical care for timely treatment.

Store in a cool, dry place, avoid direct light, below 30 degrees Celsius. Keep out of reach of children and pets.

During the use of Becovita, patients should pay attention to the following issues:
Some vitamin C contains sodium and should be avoided if you are following a diet or limiting salt. Your doctor may recommend a change in your diet so that your body can get more vitamin C. Becovita should be used with caution in pregnant and lactating women. Becovita has no significant influence on the ability to drive and use machines. In summary, Becovita is a drug belonging to the group of mineral and vitamin drugs, used in the prevention and treatment of vitamin C deficiency, in combination with other drugs in the treatment of other diseases.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.